{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:47:49Z","timestamp":1766180869817},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report the use of intravitreal triamcinolone for Susac Syndrome in one patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Case report.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000344","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T13:52:25Z","timestamp":1465566745000},"page":"236-239","source":"Crossref","is-referenced-by-count":9,"title":["INTRAVITREAL TRIAMCINOLONE IN SUSAC SYNDROME"],"prefix":"10.1097","volume":"11","author":[{"given":"Juan B.","family":"Yepez","sequence":"first","affiliation":[{"name":"Vitreoretinal Surgery Department, Clinica de Ojos, Maracaibo, Venezuela; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe A.","family":"Murati","sequence":"additional","affiliation":[{"name":"Vitreoretinal Surgery Department, Clinica de Ojos, Maracaibo, Venezuela; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Pettito","sequence":"additional","affiliation":[{"name":"Vitreoretinal Surgery Department, Clinica de Ojos, Maracaibo, Venezuela; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Fernando","family":"Arevalo","sequence":"additional","affiliation":[{"name":"Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9394(00)00377-9","article-title":"Susac syndrome","volume":"129","author":"Murata","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11940-008-0008-y","article-title":"Treatment of Susac's syndrome","volume":"10","author":"Rennebohm","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jns.2007.01.036","article-title":"Susac's syndrome: 1975-2005 microangiopathy\/autoimmune endotheliopathy","volume":"257","author":"Susac","year":"2007","journal-title":"J Neurol Sci"},{"key":"R4-20230817","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2010.08.032","article-title":"Susac's syndrome: update","volume":"299","author":"Rennebohm","year":"2010","journal-title":"J Neurol Sci"},{"key":"R5-20230817","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jns.2009.07.002","article-title":"Anti-endothelial serum antibodies in a patient with Susac's syndrome","volume":"285","author":"Jarius","year":"2009","journal-title":"J Neurol Sci"},{"key":"R6-20230817","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/IAE.0b013e31809ff824","article-title":"Fluorescein and indocyanine green angiographies in Susac syndrome","volume":"27","author":"Martinet","year":"2007","journal-title":"Retina"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3346\/jkms.2011.26.11.1518","article-title":"Recurrent bilateral branch retinal artery occlusion with hearing loss and encephalopathy: the first case report of Susac's syndrome in Korea","volume":"26","author":"Joe","year":"2011","journal-title":"J Korean Med Sci"},{"key":"R8-20230817","first-page":"375","article-title":"Petits infarctus r\u00e9tiniens, cochl\u00e9aires et c\u00e9r\u00e9braux du sujet jeune, ou SICRET syndrome ou syndrome de Susac","volume":"21","author":"Mala","year":"1998","journal-title":"J Fr Ophtalmol"},{"key":"R9-20230817","first-page":"351","article-title":"Susac's syndrome","volume":"25","author":"Susac","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006982-200602000-00020","article-title":"Intravitreal triamcinolone acetonide in Eales disease","volume":"26","author":"Agrawal","year":"2006","journal-title":"Retina"},{"key":"R11-20230817","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12348-012-0067-9","article-title":"Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy","volume":"2","author":"Huynh","year":"2012","journal-title":"J Ophthal Inflamm Infect"},{"key":"R13-20230817","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.eye.6702551","article-title":"Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series","volume":"21","author":"Ishaq","year":"2007","journal-title":"Eye (Lond)"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01271216-201701130-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T18:21:29Z","timestamp":1692296489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271216-201701130-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000344","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}